Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Biochimica Et Biophysica Acta. Molecular Cell Research|February 18, 2021
It's time to die: BH3 mimetics in solid tumorsSarah Kehr, Meike VoglerOncogene|June 3, 2018
BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosisUlrike Heinicke, Tinka Haydn, Sarah Kehr, et al.Cancer Letters|March 8, 2020
Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-X<sub>L</sub> and MCL-1 leads to rapid induction of intrinsic apoptosisSarah Kehr, Tinka Haydn, Annika Bierbrauer, et al.Advances in Medicine|November 12, 2015
Targeting BCL2-Proteins for the Treatment of Solid TumoursMeike VoglerCell Death & Disease|December 6, 2019
Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AMLLarissa Ewald, Jessica Dittmann, Meike Vogler, et al.British Journal of Cancer|March 24, 2020
A direct comparison of selective BH3-mimetics reveals BCL-X<sub>L</sub>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastomaAnnika Bierbrauer, Maureen Jacob, Meike Vogler, et al.Cancer Research|February 14, 2018
<i>NRAS</i>-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K<b>α</b>Nadezda Dolgikh, Manuela Hugle, Meike Vogler, et al.British Journal of Haematology|April 28, 2017
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatmentMeike Vogler, Harriet S Walter, Martin J S DyerCancer Letters|October 13, 2018
Identification of Smac mimetics as novel substrates for p-glycoproteinManuela Hugle, Sebastian Czaplinski, Karoline Habermann, et al.Cell Communication and Signaling : CCS|August 27, 2024
Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYCNadja M Pieper, Julia Schnell, Daniela Bruecher, et al.Pageof 5